Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial

Dateline City:  WHITEHOUSE STATION, N.J. The Company Records $493 Million Charge Reducing 2012 GAAP Results WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities class-action lawsuits. The suits are pending in the U.S. District Court for the District of New Jersey against Merck, Schering-Plough Corporation and certain of their current and former officers and directors. Language:  English Contact HTML:  MerckMedia Contacts:Ron Rogers, 908-423-6449Steve Cragle, 908-423-3461ORInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug:  Ticker: MRK Exchange: NYSE read more
Source: Merck.com - Corporate News - Category: Pharmaceuticals Authors: Tags: Corporate News Source Type: news